ARCHIVES

Two Phase II Trials Display Ramucirumab Potential Efficacy

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Recommendation By Patients; report Of Protocol Committee

August 9, 1996

Survey Shows That One-Third Of Patients Are Undertreated

April 27, 2012

Support For Translational Researchers Urgently Needed, ASCO President Says

May 22, 1998

Facing Congressional Criticism, NIH Starts Review of Extramural Conflict Policies.

June 13, 2008

GlaxoSmithKline Partners With MD Anderson, Fred Hutchinson

December 14, 2012

Obituary: Ruth Kirschstein, 82, NIH Administrator, Scientist, Mentor. House Member Softens Breast Cancer Bill

October 9, 2009